Instil Bio Inc
TIL
Market Cap$150.68M
Close$
$-11.99
142.4% downside
Current Fair Value
142.4% downsideOvervalued by 142.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $150.68 Million |
|---|---|
| Enterprise Value | $150.68 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-11.39 |
| Beta | 2.28 |
| Outstanding Shares | 6,532,658 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.92 |
|---|---|
| PEG | -11.99 |
| Price to Sales | - |
| Price to Book Ratio | 1.29 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.95 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Instil Bio Inc
150 employeesInstil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.